Kindeva Funds Additional Production Line for More Environmentally Friendly Inhalers

Kindeva Drug Delivery, a multinational supplier of pharmaceuticals-device combination goods, has invested in an additional manufacturing process to produce pressurised metered-dose inhaler devices with low environmental impact propellants.

In addition to satisfying consumer demand for more environmentally friendly produce pressurised metered-dose inhaler goods, the latest production line takes into account the European Union’s new implementation of F-gas regulations.

Kindeva’s CEO, stated: “With a track record of nearly 70 years in pMDIs — including the invention of the pMDI in 1956 and leading the CFC- to HFA-inhaler transition in the 1990s — we are excited to be a part of this industry-wide switch in the pMDI space. Kindeva is doing everything we can to ensure a greener future for all stakeholders by doubling down on our commitment to the low-GWP evolution.”